NCT00626847

Brief Summary

Glaucoma is a group of diseases in which visual loss occurs because of damage to the optic nerve. Research has shown that certain genes may cause glaucoma in some cases. So far, research has only been able to find the genes responsible for glaucoma in a small percentage of people who have glaucoma. The purpose of this project is to study the genes in patients with and without glaucoma to find additional genes that may be responsible for causing glaucoma.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
97

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Mar 2008

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 20, 2008

Completed
9 days until next milestone

First Posted

Study publicly available on registry

February 29, 2008

Completed
1 day until next milestone

Study Start

First participant enrolled

March 1, 2008

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2009

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2009

Completed
Last Updated

November 21, 2016

Status Verified

November 1, 2016

Enrollment Period

1.4 years

First QC Date

February 20, 2008

Last Update Submit

November 17, 2016

Conditions

Keywords

primary open angle glaucomaNuclear GeneticsMitochondrial DNAPOAG

Outcome Measures

Primary Outcomes (1)

  • The investigators will quantify the spectrum of changes in mitochondrial respiration, relative mitochondrial DNA content, and oxidative stress associated with different types of glaucoma.

    one blood draw

Study Arms (2)

1

Primary Open Angle Glaucoma (POAG)

2

Controls (Normals, patients without glaucoma)

Eligibility Criteria

Age40 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

glaucoma clinic

You may qualify if:

  • yrs
  • Caucasian or African American
  • Male or female with POAG, PACG, PXFG,
  • Normal

You may not qualify if:

  • Other ophthamic co-morbidities
  • Other ethnic groups
  • Unable to understand and give informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Wills Eye Glaucoma Service

Philadelphia, Pennsylvania, 19107, United States

Location

Related Publications (2)

  • Abu-Amero KK, Azad TA, Spaeth GL, Myers J, Katz LJ, Moster M, Bosley TM. Unaltered myocilin expression in the blood of primary open angle glaucoma patients. Mol Vis. 2012;18:1004-9. Epub 2012 Apr 21.

  • Abu-Amero KK, Azad TA, Spaeth GL, Myers J, Katz LJ, Moster M, Bosley TM. Absence of altered expression of optineurin in primary open angle glaucoma patients. Mol Vis. 2012;18:1421-7. Epub 2012 Jun 1.

Biospecimen

Retention: SAMPLES WITH DNA

whole blood

MeSH Terms

Conditions

Glaucoma, Open-Angle

Condition Hierarchy (Ancestors)

GlaucomaOcular HypertensionEye Diseases

Study Officials

  • George L Spaeth, MD

    Wills Eye Institute

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director Glaucoma Research Center Wills Eye; Director Medical Research and Education Glaucoma Service Foundation Wills Eye; Esposito Research Professor, Thomas Jefferson University

Study Record Dates

First Submitted

February 20, 2008

First Posted

February 29, 2008

Study Start

March 1, 2008

Primary Completion

August 1, 2009

Study Completion

August 1, 2009

Last Updated

November 21, 2016

Record last verified: 2016-11

Data Sharing

IPD Sharing
Will share

Two manuscripts have been written and published.

Locations